
|Podcasts|April 9, 2021
Study: New BPH treatments demonstrate efficacy
Author(s)Urology Times staff
The study encompassed the prostatic urethral lift (UroLift), water vapor thermal therapy (Rezum), and temporary implantable nitinol device (iTIND).
Advertisement
In this episode, Richard K. Lee, MD, MBA, discusses the recent European Urology Focus paper, New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review, for which he served as senior author. Lee is an Associate Professor of Urology and Healthcare Policy & Research at Weill Cornell Medicine Department of Urology in New York City.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Urocross shows sustained benefit through 24 months post-removal
3
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
4
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
5












